Completed NA INTERVENTIONAL 2-arm NCT03809260

A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin

A Clinical Trial for Analysis of Intestinal Microbiome Affecting Pharmacokinetics, Pharmacodynamics, and Safety of Metformin in Healthy Volunteers

Sponsor: Seoul National University Hospital

Conditions Human Microbiome

Interventions Metformin (part 1) Metformin (part 2) Vancomycin

Updated 6 times since 2019 Last updated: Oct 6, 2020 Started: Dec 1, 2018 Primary completion: Feb 28, 2019 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Human Microbiome, this trial is completed. The trial is conducted by Seoul National University Hospital and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Feb 2019 — Nov 2020 [monthly]

Recruiting NA

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seongnam-si, South Korea